JOHANNESBURG (Reuters) -South African biopharmaceutical firm Biovac on Thursday opened a state-of-the-art product development laboratory in Cape Town, backed by the Gates Foundation, to help the ...
The experimental approach, drawing on decades of research into edible vaccines, uses engineered brewer’s yeast to deliver viral antigens and was developed outside traditional clinical trials.
Chowdhury’s research team identified 75 epitopes and designed 56 immunogens – short fragments of proteins that could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results